Article From: "Allison DeAngelis"   Read full article

Roughly a month after breaking biotech IPO records to launch as a public company, Cambridge’s Moderna Therapeutics Inc. announced plans Tuesday to start several new clinical trials, including a test of its first rare disease treatment.